|
Market Closed -
London S.E.
19:35:13 14/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 59.50 GBX | 0.00% |
|
+3.48% | -26.09% |
| 08-13 | EARNINGS AND TRADING: tinybuild sues Max Ent; Light Science loss grows | AN |
| 08-13 | Arecor Therapeutics plc Publishes Clinical Data for AT278 in Peer-Reviewed Journal | CI |
| Market Cap | 22.47M 30.44M 26.29M 24.7M 42.24M 2.91B 42.93M 289M 113M 1.46B 114M 112M 4.84B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 21.15M 28.65M 24.74M 23.25M 39.75M 2.74B 40.41M 272M 107M 1.37B 108M 105M 4.56B | EV / Sales 2026 * |
24.1x | EV / Sales 2027 * | 24.4x |
| Free-Float |
46.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arecor Therapeutics plc
| 1 week | +3.48% | ||
| Current month | -2.46% | ||
| 1 month | -6.30% | ||
| 3 months | -9.85% | ||
| 6 months | -17.93% | ||
| Current year | -26.09% |
| 1 week | 56.2 |  | 65 |
| 1 month | 55.27 | | 65 |
| Current year | 55.27 | | 95 |
| 1 year | 55.27 | | 100 |
| 3 years | 35.4 | | 199 |
| 5 years | 35.4 | | 472 |
| 10 years | 35.4 | | 472 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 51 | 13/04/2021 |
David J. Ellam
DFI | Director of Finance/CFO | - | 18/11/2024 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Sarah Howell
BRD | Director/Board Member | 51 | 13/04/2021 |
Mohammad Fazeli
BRD | Director/Board Member | 61 | 01/09/2017 |
Andrew Richards
CHM | Chairman | 66 | 13/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04/06/25 | Free | Executive/Senior Manager | 85,000 | 0.2251% | ||
| 04/06/25 | Free | Chief Technology Officer | 85,000 | 0.2251% | ||
| 04/06/25 | Free | Chief Executive Officer | 66,000 | 0.1748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +3.48% | -6.30% | -69.09% | 30.32M | |
| -1.78% | -1.68% | +1.99% | +13.84% | 49.24B | |
| +0.85% | -0.70% | +465.55% | +579.03% | 43.3B | |
| -2.40% | -0.23% | +12.20% | +70.22% | 40.48B | |
| -2.01% | -0.85% | +24.95% | +7.51% | 39.75B | |
| -0.50% | +0.85% | +20.60% | +49.65% | 32.67B | |
| -0.59% | -2.06% | +26.13% | +117.79% | 16.24B | |
| +0.38% | -3.23% | - | - | 16.23B | |
| +0.49% | +0.92% | +4.32% | +22.16% | 14.04B | |
| -0.43% | +4.70% | +79.75% | +29.11% | 13.43B | |
| Average | -0.60% | +0.79% | +69.91% | +91.14% | 26.54B | |
| Weighted average by Cap. | -0.93% | +0.60% | +96.19% | +132.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 878K 1.19M 1.03M 966K 1.65M 114M 1.68M 11.32M 4.43M 56.99M 4.47M 4.37M 189M | 1.05M 1.42M 1.23M 1.15M 1.97M 136M 2.01M 13.53M 5.29M 68.12M 5.34M 5.22M 226M |
| Net income | - | - |
| Net Debt | -1.32M -1.79M -1.54M -1.45M -2.48M -171M -2.52M -17M -6.65M -85.62M -6.71M -6.57M -285M | 3.2M 4.34M 3.75M 3.52M 6.02M 415M 6.12M 41.27M 16.13M 208M 16.29M 15.94M 691M |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | GBX 59.50 | 0.00% | 95,461 |
| 13/08/26 | GBX 59.50 | 0.00% | 77,968 |
| 12/08/26 | GBX 59.50 | 0.00% | 2,048 |
| 11/08/26 | GBX 59.50 | +1.71% | 19,000 |
| 10/08/26 | GBX 58.50 | +1.74% | 69,400 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.5950GBP
Average target price
2.755GBP
Spread / Average Target
+363.03%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AREC Stock
Select your edition
All financial news and data tailored to specific country editions
